The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program

ConditionInfluenza
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age6-99
SponsorUniversity of Colorado, Denver

About this trial

This study plans to learn more about whether a stakeholder-informed, standardized inpatient vaccination program will increase influenza vaccination rates of hospitalized children across US pediatric health systems. The first part of the study is to form a multidisciplinary team of stakeholders, including parents, providers, nurses, pharmacists, informaticists, data analysts and communication experts across three sites in synthesizing a best practice implementation guide for an inpatient influenza vaccination program, which will then be piloted at these three sites.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

At least 6 months of age

Admitted to an inpatient unit at a participating health system

Disqualifiers

At least 6 months of age

Admitted to an inpatient unit at a participating health system

Trial design

Design model

Sequential

Treatments tested in this trial

  • Existing Influenza Vaccination Practices

    Other intervention

    Usual care is defined as the existing inpatient influenza vaccination practices that currently exist at a given site.

  • Standardized inpatient influenza vaccination program

    Other intervention

    Intervention A: The basic intervention is the inpatient influenza vaccination program Intervention B: The intensified intervention is the multifaceted influenza vaccination strategy (Intervention A) plus a learning collaborative

Treatment groups

22,000 Participants
are divided into 2 treatment groups
Group A: Standardized inpatient influenza vaccination programActive comparator 1 intervention
Group B: Existing inpatient influenza vaccination practicesActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Vaccine administration rate

proportion of influenza vaccine administrations to eligible patients during hospitalization.

Time frame
1 year

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Colorado, Denver

Lead sponsor

Agency for Healthcare Research and Quality (AHRQ)

Collaborator

Seattle Children's Hospital

Collaborator